Geode Capital Management’s Oragenics OGEN Stock Holding History

Geode Capital Management’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.4K	Buy	+65,072	New	+$51.5K	﹤0.01%	4376
2025 Q2	–	Sell	-2,828	Closed	-$17.8K	–	4499
2025 Q1	$17.8K	Buy	2,828 +1,545	+120%	+$13.4K	﹤0.01%	4372
2024 Q4	$14.2K	Buy	1,283 +92	+8%	+$943	﹤0.01%	4414
2024 Q3	$13.6K	Buy	1,191 +141	+13%	+$3.98K	﹤0.01%	4439
2024 Q2	$32.8K	Buy	1,050 +380	+57%	+$17.2K	﹤0.01%	4371
2024 Q1	$29K	Buy	670 +10	+2%	+$986	﹤0.01%	4423
2023 Q4	$111K	Hold	660	–	–	﹤0.01%	4152
2023 Q3	$58.8K	Buy	660 +245	+59%	+$24.5K	﹤0.01%	4381
2023 Q2	$41.2K	Hold	415	–	–	﹤0.01%	4546
2023 Q1	$41K	Hold	415	–	–	﹤0.01%	4563
2022 Q4	$78K	Sell	415 -1	-0.2%	-$353	﹤0.01%	4479
2022 Q3	$170K	Hold	416	–	–	﹤0.01%	4301
2022 Q2	$259K	Buy	416 +10	+2%	+$5.77K	﹤0.01%	4118
2022 Q1	$251K	Hold	406	–	–	﹤0.01%	4268
2021 Q4	$326K	Hold	406	–	–	﹤0.01%	4257
2021 Q3	$464K	Hold	406	–	–	﹤0.01%	4065
2021 Q2	$515K	Buy	406 +108	+36%	+$142K	﹤0.01%	3927
2021 Q1	$485K	Buy	298 +169	+131%	+$307K	﹤0.01%	3827
2020 Q4	$103K	Hold	129	–	–	﹤0.01%	4054
2020 Q3	$133K	Buy	129 +22	+21%	+$35.2K	﹤0.01%	3834
2020 Q2	$134K	Buy	+107	New	+$105K	﹤0.01%	3779
2018 Q1	–	Sell	-5	Closed	-$21K	–	4066
2017 Q4	$21K	Hold	5	–	–	﹤0.01%	3996
2017 Q3	$37K	Hold	5	–	–	﹤0.01%	3968
2017 Q2	$33K	Hold	5	–	–	﹤0.01%	4001
2017 Q1	$39K	Hold	5	–	–	﹤0.01%	3986
2016 Q4	$48K	Hold	5	–	–	﹤0.01%	3916
2016 Q3	$41K	Hold	5	–	–	﹤0.01%	3935
2016 Q2	$45K	Hold	5	–	–	﹤0.01%	3946
2016 Q1	$82	Hold	5	–	–	﹤0.01%	3881
2015 Q4	$134K	Hold	5	–	–	﹤0.01%	3811
2015 Q3	$144K	Buy	5 +3	+150%	+$122K	﹤0.01%	3788
2015 Q2	$51K	Hold	2	–	–	﹤0.01%	3859
2015 Q1	$38K	Hold	2	–	–	﹤0.01%	3876
2014 Q4	$33K	Hold	2	–	–	﹤0.01%	3924
2014 Q3	$47K	Hold	2	–	–	﹤0.01%	3839
2014 Q2	$73K	Hold	2	–	–	﹤0.01%	3737
2014 Q1	$108K	Hold	2	–	–	﹤0.01%	3643
2013 Q4	$106K	Hold	2	–	–	﹤0.01%	3588
2013 Q3	$110K	Hold	2	–	–	﹤0.01%	3474
2013 Q2	$119K	Buy	+2	New	+$113K	﹤0.01%	3388

Other funds holding OGEN

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SJIM

St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Geode Capital Management's OGEN Position: Q1 2026 in Review

Geode Capital Management opened a new position in Oragenics (OGEN) in Q1 2026: 65,072 shares worth $36.4K. The stake represents ﹤0.01% of the portfolio and ranks #4376 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in OGEN as recently as Q1 2025.

Geode Capital Management first reported a position in OGEN in Q2 2013 and has held it in 40 quarters since. The position peaked at $515K in Q2 2021. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

Geode Capital Management held 65,072 shares of Oragenics worth $36.4K as of Q1 2026.
Oragenics was a new Geode Capital Management position in Q1 2026.
Oragenics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4376 holding.
Geode Capital Management first reported a position in Oragenics in Q2 2013 and has held it in 40 quarters since.
Geode Capital Management's Oragenics position peaked at $515K in Q2 2021.
19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.